Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001554795-22-000111
Filing Date
2022-03-23
Accepted
2022-03-23 11:24:34
Documents
38
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K skin0323form10k.htm   iXBRL 10-K 291350
2 EXHIBIT 31.1 skin0323form10kexh31_1.htm EX-31.1 8134
3 EXHIBIT 31.2 skin0323form10kexh31_2.htm EX-31.2 8096
4 EXHIBIT 32.1 skin0323form10kexh32_1.htm EX-32.1 4082
  Complete submission text file 0001554795-22-000111.txt   1451792

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20211231.xsd EX-101.SCH 12261
6 XBRL CALCULATION FILE skin-20211231_cal.xml EX-101.CAL 20097
7 XBRL DEFINITION FILE skin-20211231_def.xml EX-101.DEF 13859
8 XBRL LABEL FILE skin-20211231_lab.xml EX-101.LAB 114492
9 XBRL PRESENTATION FILE skin-20211231_pre.xml EX-101.PRE 85983
32 EXTRACTED XBRL INSTANCE DOCUMENT skin0323form10k_htm.xml XML 92709
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30991 | Film No.: 22762228
SIC: 6770 Blank Checks